BJ
Barry J. Simon sold $269K of IBRX stock
Barry J. Simon, Dir of ImmunityBio, Inc. (IBRX), sold 25,000 shares of IBRX stock worth $269K, per an SEC Form 4 filed Oct 6, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Oct 5, 2026, 1 day before it was made public.
IBRX has moved -42.4% since the trade date, from $10.38 to $5.98 (Nov 16, 2026 close).
- Traded
- Oct 5, 2026
- Disclosed
- Oct 6, 2026
- Filing delay
- 1 day
- Price since
- -42.4%
- Role
- Dir
- Source
- SEC Form 4